• About us
• Contact

Advertisement

Organisation › Details

Lytix Biopharma AS

Lytix Biopharma’s technology is based on nature’s own defense mechanisms. The membranes of cancer cells are destroyed. Our unique technology is a new class of cancer immunotherapy that activates the patient`s own immune system. Lytix Biopharma’s strategy is to develop its drug candidates to end Phase II, and then collaborate with partners for the final stages of product development and commercialization. *

 

	Start	2013-11-28 existent
	Industry	cancer immunotherapy (immuno-oncology, I-O)
	Industry 2	LTX-315 (Lytix Biopharma)
	Person	Wickholm, Håkan (Lytix Biopharma AS 201603– CEO)
	Person 2	Furuseth, Torbjørn (Targovax 201809– CFO before Lytix Biopharma + Aker Biomarine + Trygg Pharma + McKinsey)
	Region	Tromsø
	Country	Norway
	City	2994 Tromsø
	Tel	+47-77-675500
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2024-02-12

Advertisement

More documents for Lytix Biopharma AS

• [1] Lytix Biopharma AS. (9/12/19). "Press Release: Lytix Biopharma AS Appoints Øystein Rekdal as the new CEO"....
• [2] Targovax ASA. (9/13/18). "Press Release: Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO". Oslo....
• [3] Redx Pharma plc. (1/22/18). "Press Release: Redx Pharma Appoints Chief Medical Officer Who Will Oversee Launch of Phase I Clinical Trial of New Cancer Drug"....
• [4] Lytix Biopharma AS. (8/22/17). "Press Release: Norwegian Cancer Society Invests in Lytix Biopharma AS"....
• [5] Lytix Biopharma AS. (8/21/17). "Press Release: Lytix Strengthens the Board with Clinical Development and Commercial Oncology Experience"....
• [6] Lytix Biopharma AS. (4/21/17). "Press Release: Lytix Biopharma Completes 1st Combination Cohort of LTX-315 and Pembrolizumab in TNBC"....
• [7] Lytix Biopharma AS. (4/20/17). "Press Release: Lytix Biopharma Raises in Total 80 Million NOK"....
• [8] Lytix Biopharma AS. (1/13/17). "Press Release: Lytix Biopharma Announces the Appointment of Torbjørn Furuseth as CFO"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.